Menu
Search
|

Menu

Close
X

Boston Scientific Corp BSX.N (New York Stock Exchange)

36.62 USD
+0.08 (+0.22%)
As of Oct 22
chart
Previous Close 36.54
Open 36.62
Volume 1,318,999
3m Avg Volume 1,584,196
Today’s High 37.00
Today’s Low 36.31
52 Week High 39.43
52 Week Low 24.54
Shares Outstanding (mil) 1,382.93
Market Capitalization (mil) 51,583.09
Forward P/E 37.84
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 24 analysts

KEY STATS

Revenue (mm, USD)
FY18
4,869
FY17
9,047
FY16
8,386
FY15
7,477
EPS (USD)
FY18
0.604
FY17
0.696
FY16
0.252
FY15
-0.179
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
37.84
32.14
Price to Sales (TTM)
vs sector
5.43
6.55
Price to Book (MRQ)
vs sector
6.65
4.00
Price to Cash Flow (TTM)
vs sector
23.11
21.51
Total Debt to Equity (MRQ)
vs sector
83.85
14.15
LT Debt to Equity (MRQ)
vs sector
62.09
11.31
Return on Investment (TTM)
vs sector
9.49
12.83
Return on Equity (TTM)
vs sector
18.33
14.95

EXECUTIVE LEADERSHIP

Michael Mahoney
Chairman of the Board, President, Chief Executive Officer, Since 2016
Salary: $1,179,450.00
Bonus: $1,890,000.00
Daniel Brennan
Chief Financial Officer, Executive Vice President, Since 2014
Salary: $593,194.00
Bonus: $504,037.00
Kevin Ballinger
Executive Vice President and Global President - Interventional Cardiology, Since 2017
Salary: $543,151.00
Bonus: $346,500.00
Joseph Fitzgerald
Executive Vice President and President - Rhythm Management, Since 2014
Salary: $564,740.00
Bonus: $595,139.00
Edward Mackey
Executive Vice President - Operations, Since 2015
Salary: $410,548.00
Bonus: $351,000.00

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

300 BOSTON SCIENTIFIC WAY
MARLBOROUGH   MA   01752-1234

Phone: +1508.6834000

Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health, Neuromodulation, and Electrophysiology. It operates in three segments: Cardiovascular, Rhythm Management and MedSurg. Its Cardiovascular segment consists of Interventional Cardiology and Peripheral Interventions businesses. Rhythm Management consists of Cardiac Rhythm Management and Electrophysiology businesses. MedSurg consists of Endoscopy, Urology and Pelvic Health, and Neuromodulation businesses. Its Interventional Cardiology product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters and embolic protection devices and diagnostic catheters used in percutaneous transluminal coronary angioplasty (PTCA) procedures.

SPONSORED STORIES